The Digestive System

  • Charles H. Duckett
  • Duane D. Webb


Gastrointestinal disease is encountered frequently in practice by most family physicians. Because of the complexities of the digestive system, including the large surface area and the multiple neural and chemical elements involved, pathologic states assume many forms.


Ulcerative Colitis Irritable Bowel Syndrome Acute Pancreatitis Chronic Pancreatitis Primary Biliary Cirrhosis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Tucker DM, Sandstead HH, Logan GM Jr, et al. Dietary fiber and personality factors as determinants of stool Output. Gastro-enterology 1981; 81: 879–83.Google Scholar
  2. 2.
    Meyer JH. Reflection on reflux gastritis (editorial). Gastroenter-ology 1979; 77: 1143–5.Google Scholar
  3. 3.
    Sauerbruch T, Schreiber MA, Schussler P, et al. Endoscopy in the diagnosis of gastritis: diagnostic value of endoscopic criteria in relation to histological diagnosis. Endoscopy 1984; 16: 101–4.PubMedCrossRefGoogle Scholar
  4. 4.
    Priebe HJ, Skillman JJ, Bushnell LS, Long PC, Silen W. Anata-cid versus Cimetidine in preventing acute gastrointestinal bleeding: a randomized trial in 75 critically ill patients. N Engl J Med 1980; 302: 426–30.PubMedCrossRefGoogle Scholar
  5. 5.
    Borrero E, Margolis IB, Bank S, et al. Antacids versus sucralfate in preventing acute gastrointestinal bleeding: a randomized trial in 100 critically ill patients. Am J Surg 1984; 148: 809–11.PubMedCrossRefGoogle Scholar
  6. 6.
    Morse DL, Gurewich JJ, Haurahan JP, et al. Widespread out-breaks of clam and oyster-associated gastroenteritis. N Engl J Med 1986; 314: 678–81.PubMedCrossRefGoogle Scholar
  7. 7.
    Veviseari T, Isolauri E, Delam A, et al. Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus Vaccine in infants vac-cinated before a rotavirus epidemic. J Pediatr 1985; 107: 189–94.CrossRefGoogle Scholar
  8. 8.
    Sullivan MA, Cohen S, Snape WJ Jr. Colonic myoelectrical activity in irritable bowel Syndrome. N Engl J Med 1978; 298: 878–83.PubMedCrossRefGoogle Scholar
  9. 9.
    Whitehead WE, Engel BT, Schuster MM. Irritable bowel Syndrome: physiological and psychological differences between di-arrhea-predominant and constipation-predominant patients. Dig Dis Sei 1980; 25: 404–13.CrossRefGoogle Scholar
  10. 10.
    Grossman MI, Kurata JH, Rotter JI, et al. Peptic ulcer: new therapies, new diseases. Ann Intern Med 1981; 95: 609–27.PubMedCrossRefGoogle Scholar
  11. 11.
    Ellis A, Woodrow JC. HLA and duodenal ulcer. Gut 1979; 20: 760–2.PubMedCrossRefGoogle Scholar
  12. 12.
    Rotter JI, Sones JQ, Samloff IM, et al. Duodenal-ulcer disease associated with elevated serum pepsinogen. I. An inherited autosomal dominant disorder. N Engl J Med 1979; 300: 63–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Sontag S, Graham D, Belsito A, et al. Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. N Engl J Med 1984; 311: 689–93.PubMedCrossRefGoogle Scholar
  14. 14.
    Dooley CP, Weiner JM, Larson AW. Endoscopy or radiogra-phy?—the patient’s choice: prospective comparative survey of patient acceptability of upper gastrointestinal endoscopy and ra-diography. Am J Med 1986; 80: 203–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Welsh JD. Diet therapy of peptic ulcer disease. Gastroenterology 1977; 72: 740–45.PubMedGoogle Scholar
  16. 16.
    Collen MJ, Howard JM, McArthur KE, et al. Comparison of ranitidine and Cimetidine in the treatment of gastric hypersecre-tion. Ann Intern Med 1984; 100: 52–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Gough KR, Korman MG, Bardhan KD, et al. Ranitidine and Cimetidine in prevention of duodenal ulcer relapse. Lancet 1984; 2: 659–62.PubMedCrossRefGoogle Scholar
  18. 18.
    Glise H, Carling L, Hallerback B, et al. Short term treatment of duodenal ulcer: a comparison of sucralfate and Cimetidine. Scand J Gastroenterol 1986; 21: 313–20.PubMedCrossRefGoogle Scholar
  19. 19.
    Hollander D, Tarmawski A, Gergely H, et al. Sucralfate protection of gastric mueosa against ethanol-induced injury: a pro-staglandin-mediated process? Scand J Gastroenterol 1984; 19 (suppl. 101): 97–102.Google Scholar
  20. 20.
    Ross AHM, Smith MA, Anderson JR, et al. Late mortality after surgery for peptic ulcer. N Engl J Med 1982; 307: 519–22.PubMedCrossRefGoogle Scholar
  21. 21.
    Richardson CT. Gastric ulcer. In: Sleisenger M, Fortran J, eds. Gastrointestinal disease. Philadelphia: Saunders, 1983; 672–93.Google Scholar
  22. 22.
    Villar LA, Massanari RM, Mitros FA. Cytomegalovirus infection with acute erosive esophagitis. Am J Med 1984; 76: 924–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Richter JE, Castell DO. Gastroesophageal reflux: pathogenesis, diagnosis, and therapy. Ann Intern Med 1982; 97: 93–103.PubMedCrossRefGoogle Scholar
  24. 24.
    Benjamin SB, Richter JE, Cordova CM, et al. Prospective man-ometric evaluation with pharmacologic provocation of patients with suspected esophageal motility dysfunction. Gastroenterol-ogy 1983; 84: 893–901.Google Scholar
  25. 25.
    Malegalada J-R. Physiologie basis and clinical significance of gastric emptying disorders (editorial). Dig Dis Sei 1979; 24: 657–61.CrossRefGoogle Scholar
  26. 26.
    Wright JT. Slipping-rib Syndrome. Lancet 1980; 2: 632–3.PubMedCrossRefGoogle Scholar
  27. 27.
    Weissmann HS, Sugarman LA, Freeman LM. The clinical role of technetium 99m iminodiacetic acid cholescintigraphy. In: Freeman LM, Weissmann HM, eds. Nuclear medicine annual. New York: Raven Press, 1981.Google Scholar
  28. 28.
    Schulze-Delrieu K. Metoclopramide. N Engl J Med 1981; 305: 28–33.PubMedCrossRefGoogle Scholar
  29. 29.
    Graham DY, Sackmann JW, Giesing DH, et al. In vitro absorp-tion of bile salts and aspirin to sucralfate. Dig Dis Sei 1984; 29: 402–6.CrossRefGoogle Scholar
  30. 30.
    Weisburger JH, Marquardt H, Mower HF, Hirota N, Mori H, Williams G. Inhibition of carcinogenesis: vitamin C and the prevention of gastric cancer. Prev Med 1980; 9: 352–61.PubMedCrossRefGoogle Scholar
  31. 31.
    Davis GR. Neoplasm of the stomach. In: Sleisenger MH, Fortran JM, eds. Gastrointestinal disease. Philadelphia: Saunders 1983: 578–603.Google Scholar
  32. 32.
    Domellof L, Eriksson S, Janunger K-G. Carcinoma and possible precancerous changes of the gastric stump after Billroth II resec-tion. Gastroenterology 1977; 73: 462–8.PubMedGoogle Scholar
  33. 33.
    MacDonald JS, Schein PS, Wooley PV, et al. 5-Fluorouracil, doxorubicin and mitomyein (FAM) combination chemotherapy for advanced gastric cancer. Ann Intern Med 1980; 93: 533–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Silverstein FE, Gilbert DA, Tedesco FJ, et al. The National American Society for Gastrointestinal Endoscopy survey on Upper gastrointestinal bleeding. Gastrointest Endosc 1981; 27: 73–102.PubMedCrossRefGoogle Scholar
  35. 35.
    Hunt PS, Hansky J, Korman MG. Mortality in patients with haematemesis and melena: a prospective study. Br Med J 1979; 1: 238–40.Google Scholar
  36. 36.
    Ostrow DJ, Mulvaney CA, Hansell JR, et al. Sensitivity and reproducibility of clinical tests for fecal occult blood with an emphasis on false positive reaction. Am J Dig Dis 1973; 18: 930–40.PubMedCrossRefGoogle Scholar
  37. 37.
    Silvoso GR, Ivey KJ, Butt JH, et al. Incidence of gastric lesions in patients with rheumatic diseases on chronic aspirin therapy. Ann Intern Med 1979; 91: 517–20.PubMedCrossRefGoogle Scholar
  38. 38.
    Hershel J, Porter J. Drug-induced gastrointestinal bleeding. Lancet 1978; 1: 87–9.Google Scholar
  39. 39.
    Weaver GA, Alpern HD, Davis JS, Ramsey WH, Reichfelderfer M. Gastrointestinal angiodysplasia associated with aortic valve disease: part of a spectrum of angiodysplasia of the gut. Gastroenterology 1979; 77: 1–11.PubMedGoogle Scholar
  40. 40.
    Gilbert DA, Saunders DS. Iced saline lavage does not slow bleeding from experimental canine gastric ulcers. Dig Dis Sei 1981; 26: 1065–8.CrossRefGoogle Scholar
  41. 41.
    Cello JP, Theoni RF. Gastrointestinal hemorrhage: comparative values of double-contrast upper gastrointestinal radiology and endoscopy. JAMA 1980; 243: 685–8.PubMedCrossRefGoogle Scholar
  42. 42.
    Peterson WI, Burnett CC, Smith HJ, et al. Routine early endoscopy in upper gastrointestinal tract bleeding. N Engl J Med 1981; 304: 925–29.PubMedCrossRefGoogle Scholar
  43. 43.
    Eastwood GL. Does the patient with upper gastrointestinal bleeding benefit from endoscopy? Reflections and discussion of recent literature. Dig Dis Sei 1981;26:22–6s. 12.Google Scholar
  44. 44.
    Koff RS. Benefit of endoscopy in Upper gastrointestinal bleeding in patients with liver disease. Dig Dis Sei 1981; 26: 12–6s.CrossRefGoogle Scholar
  45. 45.
    Griffiths WJ, Neumann DA, Welsh JD. The visible vessel as an indicator of uncontrolled or recurrent gastrointestinal hemorrhage. N Engl J Med 1979; 300: 1411–13.PubMedCrossRefGoogle Scholar
  46. 46.
    Fleischer D. Endoscopic therapy of upper gastrointestinal bleeding in humans. Gastroenterology 1986; 90: 217–34.PubMedGoogle Scholar
  47. 47.
    MacDougall BR, Westaby D, Theodossi A, et al. Increase long-term survival in variceal hemorrhage using injection sclerotherapy. Lancet 1982; 1: 124–7.PubMedCrossRefGoogle Scholar
  48. 48.
    Fogel MR, Knaur CM, Andres LL, et al. Continuous intravenous Vasopressin in active upper gastrointestinal bleeding. Ann Intern Med 1982;96:565–9. *Google Scholar
  49. 49.
    Chojkier M, Coon HO. Esophageal tamponade in the treatment of bleeding varices: a decadal progress report. Dig Dis Sei 1980; 25: 267–72.CrossRefGoogle Scholar
  50. 50.
    Teres J, Bordas JM, Rimola A, et al. Cimetidine in acute gastric mucosal bleeding: results of a double-blind randomized trial. Dig Dis Sei 1980; 25: 92–6.CrossRefGoogle Scholar
  51. 51.
    Collins R, Langman M. Treatment with histamine H2 antagonists in acute upper gastrointestinal hemorrhage. N Engl J Med 1985; 313: 660–6.PubMedCrossRefGoogle Scholar
  52. 52.
    Smith-Laing G, Scott J, Long RG, et al. Role of percutaneous transhepatic obliteration of varices in the management of hemorrhage from gastroesophageal varices. Gastroenterology 1981; 80: 1031–6.PubMedGoogle Scholar
  53. 53.
    Morson BC. Pathology of diverticular disease of the colon. Clin Gastroenterol 1975; 4: 37–52.PubMedGoogle Scholar
  54. 54.
    Lofti AM, Spencer RJ, Ilstrup DM, et al. Colorectal polyps and the risk of subsequent carcinoma. Mayo Clin Proc 1986; 61: 337–43.CrossRefGoogle Scholar
  55. 55.
    Muto T, Bussey H Jr, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36: 2251–70.PubMedCrossRefGoogle Scholar
  56. 56.
    Boley SJ, Brandt LJ, Frank MS. Severe lower intestinal bleeding: diagnosis and treatment. Clin Gastroenterol 1981; 10: 65–91.PubMedGoogle Scholar
  57. 57.
    Steer ML, Silen W. Diagnostic procedures in gastrointestinal hemorrhage. N Engl J Med 1983; 309: 646–50.PubMedCrossRefGoogle Scholar
  58. 58.
    Ranson JHC. Acute pancreatitis. Curr Probl Surg 1979; 16: 1–84.PubMedCrossRefGoogle Scholar
  59. 59.
    Mallory A, Kern F Jr. Drug-induced pancreatitis: a critical review. Gastroenterology 1980; 78: 813–20.PubMedGoogle Scholar
  60. 60.
    Mossa RA. Diagnostic tests and procedures in acute pancreatitis. N Engl J Med 1984; 311: 635–42.CrossRefGoogle Scholar
  61. 61.
    Woodard S, Kelvin FM, Rice RP, et al. Pancreatic abscess: importance of conventional radiology. AJR 1981; 136: 871–8.PubMedCrossRefGoogle Scholar
  62. 62.
    Ettien JT, Webster PD III. The management of acute pancreatitis. Adv Intern Med 1980; 25: 169–98.PubMedGoogle Scholar
  63. 63.
    Miller LJ, Ciain JE, Malagelada JR, Go VLW. Control of human postprandial pancreatic exoerine secretion: a function of the gas-troduodenal region. Dig Dis Sei 1979; 24: 150–4.CrossRefGoogle Scholar
  64. 64.
    Konturek SJ, Tasler J, Cieszkowski M, et al. Intravenous amino acids and fat stimulate pancreatic secretion. Am J Physiol 1979; 236: E678–84.PubMedGoogle Scholar
  65. 65.
    Ranson JHC. Surgical treatment of acute pancreatitis. Dis Dis Sei 1980; 25: 453–9.CrossRefGoogle Scholar
  66. 66.
    Acosta JM, Pellergrini CA, Skinner DB. Etiology and pathogene-sis of acute biliary pancreatitis. Surgery 1980; 88: 118–25.PubMedGoogle Scholar
  67. 67.
    Bradley EL III, Clements JL Jr, Gonzalez AC. The natural history of pancreatic pseudoeysts: a unified concept of management. Am J Surg 1979; 137: 135–41.PubMedCrossRefGoogle Scholar
  68. 68.
    Martin JK, Heerden JA, Bess MA. Surgical management of acute pancreatitis. Mayo Clin Proc 1984; 59: 259–67.PubMedCrossRefGoogle Scholar
  69. 69.
    Renner IG, Savage HT, Stace MH. Pancreatitis associated with alcoholic liver disease. Dig Dis Sei 1984; 29: 593–9.CrossRefGoogle Scholar
  70. 70.
    Dutta SK, Mobrahan S, Iber FL. Associated liver disease in alcoholic pancreatitis. Am J Dig Dis 1978; 23: 618–22.PubMedCrossRefGoogle Scholar
  71. 71.
    DiMagno EP. Diagnosis of chronic pancreatitis: are noninvasive tests of exoerine pancreatic function sensitive and specific? Gastroenterology 1982; 83: 143–6.PubMedGoogle Scholar
  72. 72.
    Nagata A, Homma T, Tamai K, et al. A study of chronic pancreatitis by serial endoscopic pancreatography. Gastroenterology 1981; 81: 884–91.PubMedGoogle Scholar
  73. 73.
    Ammann RW, Largiader F, Akovbiantz A. Pain relief by surgery in chronic pancreatitis? Relationship between pain relief, pancreatic dysfunction, and alcohol withdrawal. Scand J Gastroenterol 1979; 14: 209–15.PubMedCrossRefGoogle Scholar
  74. 74.
    Meshkinpour H, Molinari MD, Gardner L, et al. Cimetidine in the treatment of acute alcoholic pancreatitis: a randomized double-blind study. Gastroenterology 1979; 77: 687–90.PubMedGoogle Scholar
  75. 75.
    Durie PR, Bell L, Linton W, Corey ML, Forstner GG. Effect of Cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis. Gut 1980; 21: 778–86.PubMedCrossRefGoogle Scholar
  76. 76.
    Bell SN, Cole R, Roberts-Thomson IC. Coeliac plexus block for control of pain in chronic pancreatitis. Br Med J 1980, 281: 1604.PubMedCrossRefGoogle Scholar
  77. 77.
    Warshaw AL, Popp JW Jr, Schapiro RH. Long-term patency, pancreatic function, and pain relief after lateral pancreaticoje-junostomy for chronic pancreatitis. Gastroenterology 1980; 79: 289–93.PubMedGoogle Scholar
  78. 78.
    Hermann RE, Cooperman AM. Current concepts in cancer: cancer of the pancreas. N Engl J Med 1979; 301: 482–5.PubMedCrossRefGoogle Scholar
  79. 79.
    Goldstein HR. No association found between coffee and cancer of the pancreas (letter). N Engl J Med 1982; 306: 997.PubMedCrossRefGoogle Scholar
  80. 80.
    Beazley RM, Colin I. Pancreatic cancer. CA 1981; 31: 346–58.PubMedGoogle Scholar
  81. 81.
    Cello JP. Carcinoma of the pancreas. In: Sleisenger MH, Fortran JS, eds. Gastrointestinal disease. Philadelphia: Saunders, 1983: 1514–27.Google Scholar
  82. 82.
    Edis AJ, Kiernan PD, Taylor WF. Attempted curative resection of ductal Carcinoma of the pancreas. Mayo Clin Proc 1980; 55: 531–6.PubMedGoogle Scholar
  83. 83.
    Bornman PC, Harries-Jones EP, Tobia RG. Prospective controlled trial transhepatic biliary endoprosthesis versus bypass surgery for incurable Carcinoma of the head of the pancreas. Lancet 1986; 1: 69–71.PubMedCrossRefGoogle Scholar
  84. 84.
    Kern F. Epidemiology and national history of gallstones. Semin Liver Dis 1983; 3: 87–96.PubMedCrossRefGoogle Scholar
  85. 85.
    Thistle JL, Cleary PA, Laclin JM, et al. The natural history of cholelithiasis: the National Cooperative Gallstone Study. Ann Intern Med 1984; 101: 171–5.PubMedCrossRefGoogle Scholar
  86. 86.
    Mclntosh DM, Penney HF. Gray-scale ultrasonography as a Screening procedure in the detection of gallbladder disease. Radi-ology 1980; 136: 725–7.Google Scholar
  87. 87.
    Mujhed Z, Evans JA, Whalen JP. The nonopacified gallbladder on oral cholecystography. Radiology 1974; 122: 1–4.Google Scholar
  88. 88.
    Winzelberg GG. Radionuclide evaluation of the hepatobiliary system. Am Fam Physician 1982; 26: 203–7.PubMedGoogle Scholar
  89. 89.
    Sauerbruch T, Delius M, Paumgartner G, et al. Fragmentation of gallstones by extracorporeal shock waves. N Engl J Med 1986; 314: 818–22.PubMedCrossRefGoogle Scholar
  90. 90.
    Gracie WA, Ransohoff DF. The natural history of silent gallstones: the innocent gallstone is not a myth. N Engl J Med 1982; 307: 798–800.PubMedCrossRefGoogle Scholar
  91. 91.
    Maton PN, Iser JH, Reuben A, et al. Outcome of chenodeoxy-cholic acid (CDCA) treatment in 125 patients with radiolucent gallstones. Medicine 1982; 61: 86–97.PubMedCrossRefGoogle Scholar
  92. 92.
    Allen MJ, Borody TJ, Bugliosi TF, et al. Rapid dissolution of gallstones by methyl tert-butyl ether: preliminary observations. N Engl J Med 1985; 312: 217–20.PubMedCrossRefGoogle Scholar
  93. 93.
    Sauerbruch T, Delius M, Paumgartner G, et al. Fragmentation of gallstones by extracorporeal shock waves. N Engl J Med 1986; 314: 818–22.PubMedCrossRefGoogle Scholar
  94. 94.
    Way L, Sleisenger MH. Cholelithiasis and chronic Cholecystitis. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal disease. Philadelphia: Saunders, 1983: 1383–9.Google Scholar
  95. 95.
    Koff RS, Galambos J. Viral hepatitis. Schiff L, Schiff ER, eds. Diseases of the liver. 5th ed. Philadelphia: Lippincott, 1982: 461.Google Scholar
  96. 96.
    Sherlock S. Patterns of hematocyte injury in man. Lancet 1982; 1: 782–6.PubMedCrossRefGoogle Scholar
  97. 97.
    Szmuness W, Dienstag JL, Purcell RH, et al. Distribution of antibody to hepatitis A antigen in urban adult populations. N Engl J Med 1976; 295: 755–9.PubMedCrossRefGoogle Scholar
  98. 98.
    Dzik WH, Alter HJ. Hepatitis B viral infection. II. Public health aspects. Am Fam Physician 1982; 26: 135–42.Google Scholar
  99. 99.
    Francis DP, Hadler SC, Prendergast TJ, et al. Occurrence of hepatitis A, B, and non-A/non-B in the United States: CDC Sen-tinel County Hepatitis Study I. Am J Med 1984; 76: 69–74.PubMedCrossRefGoogle Scholar
  100. 100.
    Mann JM, Ahtone JL. Prophylaxis for hepatitis A. Am Fam Physician 1982; 25: 129–32.PubMedGoogle Scholar
  101. 101.
    Reiner NE, Judson FN, Bond WW, et al. Asymptomatic rectal mucosal lesions and hepatitis B virus infection: evidence for de-facto parenteral transmission. Ann Intern Med 1982; 96: 170–3.PubMedCrossRefGoogle Scholar
  102. 102.
    Wong VCW, Ip HMH, Reesink HW, et al. Prevention of the HBsAg carrier State in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hep-atitis-B Vaccine and hepatitis-B immunoglubulin: double-blind randomized placebo-controlled study. Lancet 1984; 1: 921–6.PubMedCrossRefGoogle Scholar
  103. 103.
    Seeff LB, Hoofnagel JH. Immunoprophylaxis of viral hepatitis. Gastroenterology 1979; 77: 161–82.PubMedGoogle Scholar
  104. 104.
    Dzik WH, Alter HJ. Hepatitis B viral infection. I. Clinical fea-tures. Am Fam Physician 1982; 26: 119–26.Google Scholar
  105. 105.
    Poiesz B, Tomar R, Lehr B, et al. Hepatitis B Vaccine evidence confirming lack of AIDS transmission. MMWR 1984; 33: 685–7.Google Scholar
  106. 106.
    Szmuness W, Stevens CE, Harley EJ, et al. Hepatitis B Vaccine: demonstration of efficacy in a controlled clinical trial in a risk population in the United States. N Engl J Med 1980; 303: 833–41.PubMedCrossRefGoogle Scholar
  107. 107.
    Haugen RK. Hepatitis after the transfusion of frozen red cells and washed red cells. N Engl J Med 1979; 301: 393–5.PubMedCrossRefGoogle Scholar
  108. 108.
    Rakela J, Rederker AG. Chronic liver disease after acute non-A, non-B viral hepatitis. Gastroenterology 1979; 77: 1200–2.PubMedGoogle Scholar
  109. 109.
    Koretz RL, Stone O, Gitnick GL. The long-term course of non- A, non-B post-transfusion hepatitis. Gastroenterology 1980: 79: 893–8.PubMedGoogle Scholar
  110. 110.
    Nicholson KG. Hepatitis delta infections. Br Med J 1985; 290: 1370–1.CrossRefGoogle Scholar
  111. 111.
    Kolts BE, Spindel E. Chronic active hepatitis. Am Fam Physician 1984; 29: 228–43.PubMedGoogle Scholar
  112. 112.
    Christensen E, Crowe J, Doniach D, et al. Clinical pattern and course of disease in primary biliary cirrhosis based on analysis of 236 patients. Gastroenterology 1980; 78: 236–46.PubMedGoogle Scholar
  113. 113.
    Boyer JL. Chronic hepatitis. In: Schiff L, Schiff G, eds. Disease of the liver. Philadelphia: Lippincott, 1982: 771–812.Google Scholar
  114. 114.
    Scott J, Collan JL, Samourian S, Sherlock S. Wilson’s disease, presenting as chronic active hepatitis. Gastroenterology 1978; 74: 645–51.PubMedGoogle Scholar
  115. 115.
    Powell LW, Bassett ML, Halliday JW. Hemochromatosis: 1980 update. Gastroenterology 1980; 78: 374–81.PubMedGoogle Scholar
  116. 116.
    Morse JO. Alpha-antitrypsin deficiency. N Engl J Med 1978; 299: 1045–78.PubMedCrossRefGoogle Scholar
  117. 117.
    Sherlock S, Dick R, VanLeeuwen DJ. Liver biopsy today: the Royal Free Hospital experience. J Hepatol 1984; 1: 75–85.CrossRefGoogle Scholar
  118. 118.
    Shattock AG, Irwin FM, Morgan BM, et al. Increased severity and morbidity of acute hepatitis in drug abusers with simulta-neously acquired hepatitis B and hepatitis D virus infections. Br Med J 1985; 290: 1377–80.CrossRefGoogle Scholar
  119. 119.
    Wright EC, Seeff LB, Berk PD, Jones A, Plötz PH. Treatment of chronic active hepatitis: an analysis of three controlled trials. Gastroenterology 1979; 73: 1422–30.Google Scholar
  120. 120.
    Lam KC, Lai CL, Ng RP, et al. Deleterious effect of predniso-lone in HBsAg-positive chronic active hepatitis. N Engl J Med 1981; 304: 380–6.PubMedCrossRefGoogle Scholar
  121. 121.
    Matloff DS, Alpert E, Resnick R, et al. A prospective trial of D. penicillamine in primary biliary cirrhosis. N Engl J Med 1982; 306: 319–26.PubMedCrossRefGoogle Scholar
  122. 122.
    Starzl TE, Iwatsuki S, Shaw BW, et al. Analysis of liver trans-plantation. Hepatology 1984; 4: 47S - 9S.PubMedCrossRefGoogle Scholar
  123. 123.
    Lelbach WK. Epidemiology of alcoholic liver disease. Prog Liver Dis 1976; 5: 494–515.PubMedGoogle Scholar
  124. 124.
    Galambos JT. Natural history of alcoholic hepatitis. 3. Histologie changes. Gastroenterology 1972; 63: 1026–35.PubMedGoogle Scholar
  125. 125.
    Mendenhall CL, Anderson S, Garcia-Pont P, et al. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med 1984; 311: 1464–70.PubMedCrossRefGoogle Scholar
  126. 126.
    Anthony PP, Ishak KG, Nayak NC, et al. The morphology of cirrhosis: definition, nomenclature, and classificiation. Bull WHO 1977; 55: 521–40.PubMedGoogle Scholar
  127. 127.
    Sherlock S. Hepatic cirrhosis. In: Sherlock S, ed. Diseases of the liver and biliary system. 6th ed. Oxford: Blackwell, 1981: 323–33.Google Scholar
  128. 128.
    Epstein M. Deranged sodium homeostasis in cirrhosis. Gastroenterology 1979; 76: 622–35.PubMedGoogle Scholar
  129. 129.
    Barthel JS, Butt JH II. Ascites. Am Fam Physician 1983: 27: 248–57.Google Scholar
  130. 130.
    Gregory PB, Broekelschen PH, Hill MD, et al. Complications of diuresis in the alcoholic patient with ascites: a controlled trial. Gastroenterology 1977; 73: 534–8.PubMedGoogle Scholar
  131. 131.
    Blendis LM, Greig PD, Langer B, Baigrie RS, Ruse J, Taylor BR. The renal and hemodynamic effects of the peritoneovenous shunt for intractable hepatic ascites. Gastroenterology 1979; 77: 250–7.PubMedGoogle Scholar
  132. 132.
    Fräser CL, Arieff AL. Hepatic eneephalopathy. N Engl J Med 1985; 313: 865–73.PubMedCrossRefGoogle Scholar
  133. 133.
    Omata M, Ashcaval M, Liew C-T, Peters RL. Hepatocellular Carcinoma in the U.S.A., etiologic considerations. Gastroenterology 1979; 76: 279–87.PubMedGoogle Scholar
  134. 134.
    Mitchell JR. Isoniazid liver injury: clinical spectrum, pathology, and probably pathogenesis. Ann Intern Med 1976; 84: 181–92.PubMedCrossRefGoogle Scholar
  135. 135.
    Maddrey WC. Drug-related acute and chronic hepatitis. Clin Gastroenterol 1980; 9: 213–24.PubMedGoogle Scholar
  136. 136.
    Varma RR, Riedel DR, Komorowski RA, et al. Reye’s Syndrome in nonpediatric age groups. JAMA 1979; 242: 1373–5.PubMedCrossRefGoogle Scholar
  137. 137.
    Waldman RJ, Hall WN, McGee H, et al. Aspirin as a risk factor in Reye’s Syndrome. JAMA 1982; 247: 3089–94.PubMedCrossRefGoogle Scholar
  138. 138.
    Greegor DH. Occult blood testing for detection of asymptomatic colon cancer. Cancer 1971; 28: 131–4.PubMedCrossRefGoogle Scholar
  139. 139.
    Winawher SJ, Fleisher M, Baldwin M, et al. Current status of fecal occult blood testing and Screening for colorectal cancer. CA 1982; 32: 100–12.Google Scholar
  140. 140.
    Gnauck R, Macray FA, Fleisher M. How to perform fecal occult blood test. CA 1984; 34: 134–47.PubMedGoogle Scholar
  141. Macray FA, St. John DJ. Relationship between patterns of bleeding and hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology 1982;82:891–8.Google Scholar
  142. 142.
    American Cancer Society. Cancer facts and figures, 1985. New York: ACS, 1985: 9.Google Scholar
  143. 143.
    Chernoff R. Nutritional support: formulas and delivery of enteral feeding. J Am Diet Assoc 1981; 79: 420–32.Google Scholar

Copyright information

© Springer Science+Business Media New York 1988

Authors and Affiliations

  • Charles H. Duckett
  • Duane D. Webb

There are no affiliations available

Personalised recommendations